Care pathway management leader Lumeon recently announced it is receiving $28 million in funds from an investment led by European health care investment firm LSP. Lumeon will use the funding to grow its U.S. team and headquarters in Boston, scale operations, and accelerate consumer deployment.
Also participating in the funding were MTIP, Gilde, Amadeus Capital Partners, and IPF Partners. With the funding, Lumeon will now be more empowered to help provider organizations delivery next-generation care and personalized care that combines intelligent orchestration and automation. LSP cited Lumeon’s commercially validated and results-driven platforms as a primary reason for its interest in investing in the organization.
Lumeon enables health care provider organizations to orchestrate and automate systems and processes, bringing situational awareness to care operations to deliver high performance, team-centered health care. The industry-leading Lumeon Care Pathway Management (CPM) platform and suite of solutions empower health provider organizations to take control of their end-to-end care delivery model and maximize the use of resources.
This was reported by Business Wire on December 4, 2018.
Contact Information: Lumeon North American Headquarters, 90 Canal Street, Boston, Massachusetts 02114; (888) 450-3195; Website: www.lumeon.com